4//SEC Filing
Sun Nelson 4
Accession 0000950170-25-023243
CIK 0001774857other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:30 PM ET
Size
8.3 KB
Accession
0000950170-25-023243
Insider Transaction Report
Form 4
Sun Nelson
Chief Financial Officer
Transactions
- Conversion
Common Stock
2025-02-14+7,001→ 89,484 total - Purchase
Common Stock
2025-02-14$16.00/sh+10,000$160,000→ 99,484 total - Conversion
Series C Convertible Preferred Stock
2025-02-14−59,332→ 0 total→ Common Stock (7,001 underlying)
Footnotes (1)
- [F1]The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date.
Documents
Issuer
Aardvark Therapeutics, Inc.
CIK 0001774857
Entity typeother
Related Parties
1- filerCIK 0002045377
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:30 PM ET
- Size
- 8.3 KB